NCT05439694 is a Phase 4 clinical trial of Tranexamic acid in Rectus Sheath Hematoma, sponsored by Cairo University.

Who is sponsoring NCT05439694?

NCT05439694 is sponsored by Cairo University.

What drugs are being tested in NCT05439694?

Interventions in NCT05439694: Tranexamic acid.

What condition does NCT05439694 study?

NCT05439694 studies Rectus Sheath Hematoma, Cesarean Section.

Is NCT05439694 still recruiting?

NCT05439694 is currently completed. Last updated 21 February 2023.

Last reviewed 2023-02-21 · How we verify

NCT05439694

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

TXA Soaked Gelatin Sponge to Reduce Rectus Sheath Hematoma After C.S. in Patients Using Warfarin

Completed Phase 4 Last updated 21 February 2023

What this trial tests

Phase 4 trial testing Tranexamic acid in Rectus Sheath Hematoma in 63 participants. Completed in 1 February 2023.

Timeline

3 July 2022

Primary endpoint
1 January 2023

1 February 2023

Quick facts

Lead sponsor	Cairo University
Phase	Phase 4
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	prevention
Enrollment	63
Start date	3 July 2022
Primary completion	1 January 2023
Estimated completion	1 February 2023
Sites	1 location across Egypt

Drugs / interventions tested

Tranexamic acid (Tranexamic Acid) — full drug profile →

Conditions studied

Rectus Sheath Hematoma — all drugs for Rectus Sheath Hematoma →
Cesarean Section — all drugs for Cesarean Section →

Sponsor

Cairo University

Who can join

Adults 20 to 40, female only, with Rectus Sheath Hematoma or Cesarean Section. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this randomized controlled study is to demonstrate the effect of Local application of TXA impregnated in a gelatin sponge in reducing Rectus sheath hematoma formation in patients treated with warfarin following cesarean section.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Role of tranexamic acid-soaked gelatin sponge in minimizing rectus sheath hematoma after cesarean section in women treated with warfarin, a simple tool for high-risk cases, a randomized controlled trial.
Hany A, Mansour A, Sediek M, Nabil M. · · 2023 · cited 2× · PMID 37864195 · DOI 10.1186/s40001-023-01434-7

Verify or expand the search:

Other trials of Tranexamic acid

Trials testing the same drug.

NCT07278037 — Trends in the Administration of Tranexamic Acid for Postpartum Hemorrhage · recruiting
NCT06599762 — Evaluation of Tranexamic Acid in Myelodysplastic Syndromes and Acute Myeloid Leukemia · Phase 2 · recruiting
NCT06657924 — Preoperative Tranexamic Acid (TXA) to Prevent Bleeding in Patients Undergoing Major Colorectal Surgery · Phase 2 · recruiting
NCT06806241 — Effects of Tranexamic Acid Irrigation on Impacted Third Molar Surgery · recruiting
NCT06419075 — Tranexamic Acid in Vaginal Reconstructive Surgery · Phase 4 · withdrawn

Other Cairo University trials

Trials by the same sponsor.

NCT04155528 — Effect of Music Therapy on Postoperative Health Outcomes · NA · not yet recruiting
NCT07363239 — CBCT-Based Safety Distance for Implant Placement Near the Inferior Alveolar Canal · not yet recruiting
NCT07374575 — Egyptian Dental Professionals' Perspectives on the Oral Microbiome and Exosomes · not yet recruiting
NCT07381153 — In-Vitro Cytotoxicity Assessment of INOX (Nanoksa G Plus) Polymer Discs · not yet recruiting
NCT07375394 — 3D-Printed Extraoral Camera for Standardized Dental Photography · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05439694 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 9 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Cairo University
Last refreshed: 21 February 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05439694.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing